BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19139363)

  • 1. Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study.
    Coker LH; Hogan PE; Bryan NR; Kuller LH; Margolis KL; Bettermann K; Wallace RB; Lao Z; Freeman R; Stefanick ML; Shumaker SA
    Neurology; 2009 Jan; 72(2):125-34. PubMed ID: 19139363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study.
    Resnick SM; Espeland MA; Jaramillo SA; Hirsch C; Stefanick ML; Murray AM; Ockene J; Davatzikos C
    Neurology; 2009 Jan; 72(2):135-42. PubMed ID: 19139364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
    JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
    Espeland MA; Rapp SR; Shumaker SA; Brunner R; Manson JE; Sherwin BB; Hsia J; Margolis KL; Hogan PE; Wallace R; Dailey M; Freeman R; Hays J;
    JAMA; 2004 Jun; 291(24):2959-68. PubMed ID: 15213207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS).
    Coker LH; Espeland MA; Rapp SR; Legault C; Resnick SM; Hogan P; Gaussoin S; Dailey M; Shumaker SA
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):304-10. PubMed ID: 19932751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in brain and lesion volumes after CEE therapies: the WHIMS-MRI studies.
    Coker LH; Espeland MA; Hogan PE; Resnick SM; Bryan RN; Robinson JG; Goveas JS; Davatzikos C; Kuller LH; Williamson JD; Bushnell CD; Shumaker SA;
    Neurology; 2014 Feb; 82(5):427-34. PubMed ID: 24384646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials.
    Swica Y; Warren MP; Manson JE; Aragaki AK; Bassuk SS; Shimbo D; Kaunitz A; Rossouw J; Stefanick ML; Womack CR
    Menopause; 2018 Jul; 25(7):753-761. PubMed ID: 29381666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Hearing Loss and Menopausal Hormone Therapy With Change in Global Cognition and Incident Cognitive Impairment Among Postmenopausal Women.
    Armstrong NM; Espeland MA; Chen JC; Masaki K; Wactawski-Wende J; Li W; Gass MLS; Stefanick ML; Manson JE; Deal JA; Rapp SR; Lin FR; Resnick SM
    J Gerontol A Biol Sci Med Sci; 2020 Feb; 75(3):537-544. PubMed ID: 31326978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.
    Manson JE; Aragaki AK; Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Chlebowski RT; Howard BV; Thomson CA; Margolis KL; Lewis CE; Stefanick ML; Jackson RD; Johnson KC; Martin LW; Shumaker SA; Espeland MA; Wactawski-Wende J;
    JAMA; 2017 Sep; 318(10):927-938. PubMed ID: 28898378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain volumes, cognitive impairment, and conjugated equine estrogens.
    Espeland MA; Tindle HA; Bushnell CA; Jaramillo SA; Kuller LH; Margolis KL; Mysiw WJ; Maldjian JA; Melhem ER; Resnick SM;
    J Gerontol A Biol Sci Med Sci; 2009 Dec; 64(12):1243-50. PubMed ID: 19729392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Shumaker SA; Legault C; Rapp SR; Thal L; Wallace RB; Ockene JK; Hendrix SL; Jones BN; Assaf AR; Jackson RD; Kotchen JM; Wassertheil-Smoller S; Wactawski-Wende J;
    JAMA; 2003 May; 289(20):2651-62. PubMed ID: 12771112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.
    Maki PM; Henderson VW
    Climacteric; 2012 Jun; 15(3):256-62. PubMed ID: 22612612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y).
    Vaughan L; Espeland MA; Snively B; Shumaker SA; Rapp SR; Shupe J; Robinson JG; Sarto GE; Resnick SM;
    Brain Res; 2013 Jun; 1514():3-11. PubMed ID: 23578696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone replacement therapy and cognitive function].
    Huang CP; Hong CT; Huang IT
    Acta Neurol Taiwan; 2006 Dec; 15(4):273-7. PubMed ID: 17214093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combination estrogen plus progestin hormone treatment on cognition and affect.
    Resnick SM; Maki PM; Rapp SR; Espeland MA; Brunner R; Coker LH; Granek IA; Hogan P; Ockene JK; Shumaker SA;
    J Clin Endocrinol Metab; 2006 May; 91(5):1802-10. PubMed ID: 16522699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects.
    Zhao S; Chlebowski RT; Anderson GL; Kuller LH; Manson JE; Gass M; Patterson R; Rohan TE; Lane DS; Beresford SA; Lavasani S; Rossouw JE; Prentice RL
    Breast Cancer Res; 2014 Mar; 16(2):R30. PubMed ID: 24670297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estrogen with and without progestin on urinary incontinence.
    Hendrix SL; Cochrane BB; Nygaard IE; Handa VL; Barnabei VM; Iglesia C; Aragaki A; Naughton MJ; Wallace RB; McNeeley SG
    JAMA; 2005 Feb; 293(8):935-48. PubMed ID: 15728164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
    Chlebowski RT; Anderson GL; Aragaki AK; Manson JE; Stefanick ML; Pan K; Barrington W; Kuller LH; Simon MS; Lane D; Johnson KC; Rohan TE; Gass MLS; Cauley JA; Paskett ED; Sattari M; Prentice RL
    JAMA; 2020 Jul; 324(4):369-380. PubMed ID: 32721007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic Effects of Hormone Therapy and Associations With Coronary Heart Disease Among Postmenopausal Women.
    Balasubramanian R; Demler O; Guasch-Ferré M; Paynter NP; Sheehan R; Liu S; Manson JE; Salas-Salvadó J; Martínez-Gonzalez MÁ; Hu FB; Clish C; Rexrode KM
    Circ Genom Precis Med; 2020 Dec; 13(6):e002977. PubMed ID: 33141616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.